Availability of iron sorbitol for hemoglobin formation as studied with phlebotomy.
D000284:Administration, Oral; D000328:Adult; D000747:Anemia, Hypochromic / Q000097:blood* / Q000188:drug therapy / Q000378:metabolism; D001810:Blood Volume; D001815:Bloodletting; D001853:Bone Marrow / Q000032:analysis; D001854:Bone Marrow Cells; D002986:Clinical Trials as Topic; D003676:Deferoxamine; D004338:Drug Combinations; D006454:Hemoglobins / Q000096:biosynthesis*; D006485:Hemosiderin / Q000032:analysis; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D008297:Male; D013012:Sorbitol / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
D004338:Drug Combinations; D006454:Hemoglobins; D013012:Sorbitol; D006485:Hemosiderin; D007501:Iron; D003676:Deferoxamine